Your browser doesn't support javascript.
Genomic surveillance of COVID-19 cases in Beijing.
Du, Pengcheng; Ding, Nan; Li, Jiarui; Zhang, Fujie; Wang, Qi; Chen, Zhihai; Song, Chuan; Han, Kai; Xie, Wen; Liu, Jingyuan; Wang, Linghang; Wei, Lirong; Ma, Shanfang; Hua, Mingxi; Yu, Fengting; Wang, Lin; Wang, Wei; An, Kang; Chen, Jianjun; Liu, Haizhou; Gao, Guiju; Wang, Sa; Huang, Yanyi; Wu, Angela R; Wang, Jianbin; Liu, Di; Zeng, Hui; Chen, Chen.
  • Du P; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Ding N; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Li J; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Zhang F; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Wang Q; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Chen Z; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Song C; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Han K; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Xie W; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Liu J; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Wang L; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Wei L; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Ma S; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Hua M; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Yu F; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Wang L; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Wang W; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • An K; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Chen J; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Liu H; Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, 100015, People's Republic of China.
  • Gao G; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
  • Wang S; MGI, BGI-Shenzhen, Shenzhen, 518083, People's Republic of China.
  • Huang Y; MGI, BGI-Shenzhen, Shenzhen, 518083, People's Republic of China.
  • Wu AR; BGI-Genomics, BGI-Shenzhen, Shenzhen, 518083, People's Republic of China.
  • Wang J; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.
  • Liu D; National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.
  • Zeng H; National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.
  • Chen C; Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
Nat Commun ; 11(1): 5503, 2020 10 30.
Article in English | MEDLINE | ID: covidwho-894393
ABSTRACT
The spread of SARS-CoV-2 in Beijing before May, 2020 resulted from transmission following both domestic and global importation of cases. Here we present genomic surveillance data on 102 imported cases, which account for 17.2% of the total cases in Beijing. Our data suggest that all of the cases in Beijing can be broadly classified into one of three groups Wuhan exposure, local transmission and overseas imports. We classify all sequenced genomes into seven clusters based on representative high-frequency single nucleotide polymorphisms (SNPs). Genomic comparisons reveal higher genomic diversity in the imported group compared to both the Wuhan exposure and local transmission groups, indicating continuous genomic evolution during global transmission. The imported group show region-specific SNPs, while the intra-host single nucleotide variations present as random features, and show no significant differences among groups. Epidemiological data suggest that detection of cases at immigration with mandatory quarantine may be an effective way to prevent recurring outbreaks triggered by imported cases. Notably, we also identify a set of novel indels. Our data imply that SARS-CoV-2 genomes may have high mutational tolerance.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Observational study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Observational study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article